Plain-English translation of NCT04448145 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand what happens to people after they recover from COVID-19 — specifically, whether the virus stays in the body in certain places and what long-term effects people may experience. This observational study will follow up to 800 people from the New York City area over two years, collecting blood samples and samples from different body sites, along with information about their health and symptoms.
Many people report ongoing health problems months after their COVID-19 illness, but doctors don't fully understand why this happens or who is most at risk. This study aims to identify which people are more likely to have long-term effects and whether traces of the virus in the body play a role.
You likely qualify if…
You likely don't qualify if…
You would start with a baseline visit where you answer questions about your health, COVID-19 illness, and provide blood and body site samples. Then you would return for follow-up visits over the next two years — up to 12 visits total — where researchers would check on your health, collect additional samples, and ask about any lingering symptoms or health changes. The entire study period lasts 24 months after your COVID-19 symptoms began.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States